Company
Technology
Products
Support

Technology

product_logo

Switching™ PCR Technology

HB Switching™ PCR Technology is an Ultra-High Sensitive PCR platform with a Limit of Detection of <10¹ copies per reaction. A limitation of conventional PCR or Real-Time PCR is low sensitivity that may lead to false positive results.

This is addressed by providing an alternative PCR technique with significantly higher accuracy.

Liquid Biopsy
for Nucleic Acid Analysis

Conventional
Switching™

1.

Low concentrations of target genetic materials in body fluids such as blood and urine.

2.

Requires diagnostic tools with high sensitivity, such as Nested PCR, to detect extremely low concentrations.

3.

False negative results are possible.

Edit Template

1.

Reduce false positives by detecting extremely low concentrations of genetic material with high sensitivity.

2.

Accurate diagnosis with reduced run time and low risk of cross-contamination compared to Nested PCR.

3.

Compatible with conventional PCR and Real-Time PCR

Edit Template
switching_img01

Limit of Detection of <10¹ copies/rxn

High Sensitivity

Early detection of cancer and other diseases.

Minimally-invasive and quicker analysis

Related Products

egfr_visual
product_logo

SwitchPlex™
T790M Kit

HB SwitchPlex™ T790M Kit is used to prescribe the secondary targeted anticancer drug called Osimertinib to patients with positive results with EGFR T790M mutation.

respiratory_img
product_logo

SwitchPlex™
Respiratory Virus
Duplex Kit

HB SwitchPlex™ Respiratory Virus Duplex Kits consist of 4 products derived from HB Switching™ PCR technology, an Ultra-High Sensitive PCR platform to diagnose 7 respiratory viruses. Each kit has a high sensitivity with a limit of detection of 10⁰ copies.